LP
NEUE

LMR Partners’s NeueHealth NEUE Stock Holding History

LMR Partners’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-292
Closed -$25K – 1297
2022
Q3 		$25K Hold
292
– – ﹤0.01% 1147
2022
Q2 		$43K Buy
+292
New +$42.5K ﹤0.01% 1172
2021
Q3 		– Sell
-1,250
Closed -$1.72M – 1228
2021
Q2 		$1.72M Buy
+1,250
New +$1.71M 0.03% 403

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LMR Partners's NEUE Position: Q4 2022 in Review

LMR Partners sold out of NeueHealth (NEUE) in Q4 2022, closing a stake of 292 shares — an estimated $25K sold.

LMR Partners first reported a position in NEUE in Q2 2021 and held it in 3 quarters. The position peaked at $1.72M in Q2 2021. 127 funds tracked by Wall St. Rank hold NEUE as of Q4 2022.

  • LMR Partners reported no remaining NeueHealth position as of Q4 2022 after selling out during the quarter.
  • LMR Partners sold 292 NeueHealth shares in Q4 2022, an estimated $25K.
  • LMR Partners first reported a position in NeueHealth in Q2 2021 and held it in 3 quarters.
  • LMR Partners's NeueHealth position peaked at $1.72M in Q2 2021.
  • 127 funds tracked by Wall St. Rank held NeueHealth as of Q4 2022.

Based on LMR Partners's 13F filing for Q4 2022, filed 14 Feb 2023.